Institutional shares held 253,318
0 calls
0 puts
Total value of holdings $179K
$0 calls
$0 puts
Market Cap $133M
187,776,992 Shares Out.
Institutional ownership 0.13%
# of Institutions 4


Latest Institutional Activity in DBVT

Top Purchases

Q1 2024
Morgan Stanley Shares Held: 632K ($449K)
Q1 2024
Yiheng Capital Management, L.P. Shares Held: 5.57M ($3.95M)
Q1 2024
Xtx Topco LTD Shares Held: 12.6K ($8.96K)
Q1 2024
Nbc Securities, Inc. Shares Held: 5K ($3.55K)
Q1 2024
Jgp Global Gestao De Recursos Ltda. Shares Held: 11.9K ($8.45K)

Top Sells

Q2 2024
Boxer Capital, LLC Shares Held: 250K ($178K)
Q2 2024
Advisor Group Holdings, Inc. Shares Held: 117 ($83.1)
Q1 2024
Hrt Financial LP Shares Held: 101K ($71.8K)
Q1 2024
Millennium Management LLC Shares Held: 585K ($415K)
Q1 2024
Landscape Capital Management, L.L.C. Shares Held: 89.9K ($63.9K)

About DBVT

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.


Insider Transactions at DBVT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
72.9K Shares
From 4 Insiders
Open market or private purchase 18.9K shares
Grant, award, or other acquisition 54K shares
Sell / Disposition
5.07K Shares
From 1 Insiders
Open market or private sale 5.07K shares

Track Institutional and Insider Activities on DBVT

Follow DBV Technologies S.A. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DBVT shares.

Notify only if

Insider Trading

Get notified when an Dbv Technologies S.A. insider buys or sells DBVT shares.

Notify only if

News

Receive news related to DBV Technologies S.A.

Track Activities on DBVT